Compare J.B.Chemicals with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AUROBINDO PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AUROBINDO PHARMA J.B.CHEMICALS/
AUROBINDO PHARMA
 
P/E (TTM) x 22.5 16.0 140.9% View Chart
P/BV x 4.2 3.3 128.0% View Chart
Dividend Yield % 0.3 0.3 87.3%  

Financials

 J.B.CHEMICALS   AUROBINDO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA
Mar-19
J.B.CHEMICALS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs363830 43.7%   
Low Rs255527 48.4%   
Sales per share (Unadj.) Rs169.1333.9 50.7%  
Earnings per share (Unadj.) Rs16.640.4 41.1%  
Cash flow per share (Unadj.) Rs23.451.8 45.2%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.60.4 175.6%  
Book value per share (Unadj.) Rs172.5237.1 72.8%  
Shares outstanding (eoy) m83.57585.91 14.3%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.0 89.9%   
Avg P/E ratio x18.616.8 110.7%  
P/CF ratio (eoy) x13.213.1 100.7%  
Price / Book Value ratio x1.82.9 62.6%  
Dividend payout %12.06.2 194.5%   
Avg Mkt Cap Rs m25,827397,569 6.5%   
No. of employees `0003.817.9 21.1%   
Total wages/salary Rs m2,51125,849 9.7%   
Avg. sales/employee Rs Th3,747.410,956.9 34.2%   
Avg. wages/employee Rs Th665.71,447.7 46.0%   
Avg. net profit/employee Rs Th367.81,324.3 27.8%   
INCOME DATA
Net Sales Rs m14,135195,636 7.2%  
Other income Rs m3661,553 23.6%   
Total revenues Rs m14,501197,189 7.4%   
Gross profit Rs m2,17839,519 5.5%  
Depreciation Rs m5706,680 8.5%   
Interest Rs m352,626 1.3%   
Profit before tax Rs m1,94031,767 6.1%   
Minority Interest Rs m027 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-881 0.0%   
Tax Rs m5527,269 7.6%   
Profit after tax Rs m1,38723,645 5.9%  
Gross profit margin %15.420.2 76.3%  
Effective tax rate %28.522.9 124.5%   
Net profit margin %9.812.1 81.2%  
BALANCE SHEET DATA
Current assets Rs m10,470153,645 6.8%   
Current liabilities Rs m2,749120,429 2.3%   
Net working cap to sales %54.617.0 321.7%  
Current ratio x3.81.3 298.5%  
Inventory Days Days55135 40.8%  
Debtors Days Days7864 121.9%  
Net fixed assets Rs m5,811103,909 5.6%   
Share capital Rs m167586 28.5%   
"Free" reserves Rs m14,248138,322 10.3%   
Net worth Rs m14,416138,908 10.4%   
Long term debt Rs m01,800 0.0%   
Total assets Rs m17,649264,544 6.7%  
Interest coverage x56.613.1 431.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.7 108.3%   
Return on assets %8.19.9 81.1%  
Return on equity %9.617.0 56.5%  
Return on capital %13.723.8 57.5%  
Exports to sales %049.6 0.0%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs mNA97,091 0.0%   
Imports (cif) Rs mNA36,741 0.0%   
Fx inflow Rs m6,16497,316 6.3%   
Fx outflow Rs m1,33440,589 3.3%   
Net fx Rs m4,82956,727 8.5%   
CASH FLOW
From Operations Rs m1,23116,220 7.6%  
From Investments Rs m-208-28,768 0.7%  
From Financial Activity Rs m-59519,191 -3.1%  
Net Cashflow Rs m4276,656 6.4%  

Share Holding

Indian Promoters % 55.4 54.1 102.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 8.0 42.6%  
FIIs % 3.9 27.7 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.2 362.7%  
Shareholders   30,437 69,601 43.7%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  ELDER PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)

Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 7, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS